RVL Pharmaceuticals

Public

RVL Pharmaceuticals is now publicly traded

The data on this page reflects RVL Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Oct 17, 2018

Last Round

Private Placement

Aug 15, 2023

Total Funding Raised

$236.93M

Company Overview

RVL Pharmaceuticals has raised $236.93M. It was founded in 2000.

RVL Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes eyecare and medical aesthetics products, including its FDA-approved product UPNEEQ® for droopy eyelids.

AI Layer

Non-AI

RVL Pharmaceuticals Comparables

Compare RVL Pharmaceuticals with similar companies based on industry and business-model similarity.

No comparables are published for RVL Pharmaceuticals. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

RVL Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Aug 15, 2023	Demo	Demo	Demo	Demo
Private Placement	Aug 8, 2022	Demo	Demo	Demo	Demo
Debt	Aug 4, 2022	Demo	Demo	Demo	Demo
Follow-on Offering	Oct 12, 2021	Demo	Demo	Demo	Demo
Debt	Oct 7, 2021	Demo	Demo	Demo	Demo
Follow-on Offering	Jul 16, 2020	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Lori Deo

Chief Executive Officer

Executive Team

JD Schaub

EVP, COO

Executive Team

For institutional investors. Book with your work email.

RVL Pharmaceuticals Investors

Notable investors and investment history

RVL Pharmaceuticals investors
Investor	Rounds
Jefferies	IPO
H.C. Wainwright & Co.	Follow-on Offering
Athyrium Capital Management	Private Placement, Debt
RBC Capital Markets	IPO
Wells Fargo Securities	IPO
Avista Capital Partners	Debt, IPO, Private Placement

RVL Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

RVL Pharmaceuticals filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Firmographic Details

Headquarters—

Employee Range60

Year Founded2000

Last FundingAug 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?